Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

P. Hadji(1), N. Papaioannou(2), E. Gielen(3), M. Feudjo Tepie(4), E. Zhang(4), I. Frieling(5), P. Geusens(6,7), P. Makras(8), H. Resch(9), G. Möller(1)(0), L. Kalouche-Khalil(1)(1), A. Fahrleitner-Pammer(1)(2)

May 28 2015

1 Department of Obstetrics and Gynecology, Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488 Frankfurt, Germany
2 Medical School, Laboratory of Research of Myoskeletal Diseases, KAT Hospital, University of Athens, Athens, Greece
3 Department of Geriatrics and the Centre for Metabolic Bone Diseases, UZ Leuven, Leuven, Belgium
4 Amgen Ltd, Uxbridge, UK
5 Osteoporosis Center, Hamburg, Germany
6 Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands
7 University Hasselt, Diepenbeek, Belgium
8 Department of Endocrinology and Diabetes, 251 Hellenic Airforce and VA General Hospital, Athens, Greece
9 St Vincent Hospital, Medical Department II, Academic Teaching Hospital of the Medical University of Vienna, Vienna, Austria
10 Practice for Preventive and Regenerative Medicine, Staufen im Breisgau, Germany
11 Amgen (Europe) GmbH, Zug, Switzerland
12 Department of Endocrinology and Metabolism, Medical University Graz, Graz, Austria


Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on and read the journal contents on
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.